150 related articles for article (PubMed ID: 2380761)
1. Chemotherapy of invasive thymoma.
Fornasiero A; Daniele O; Ghiotto C; Sartori F; Rea F; Piazza M; Fiore-Donati L; Morandi P; Aversa SM; Paccagnella A
J Clin Oncol; 1990 Aug; 8(8):1419-23. PubMed ID: 2380761
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy for invasive thymoma. A 13-year experience.
Fornasiero A; Daniele O; Ghiotto C; Piazza M; Fiore-Donati L; Calabró F; Rea F; Fiorentino MV
Cancer; 1991 Jul; 68(1):30-3. PubMed ID: 2049749
[TBL] [Abstract][Full Text] [Related]
3. Intensive chemotherapy with cisplatin, doxorubicin, cyclophosphamide, etoposide and granulocyte colony-stimulating factor for advanced thymoma or thymic cancer: preliminary results.
Oshita F; Kasai T; Kurata T; Fukuda M; Yamamoto N; Ohe Y; Tamura T; Eguchi K; Shinkai T; Saijo N
Jpn J Clin Oncol; 1995 Oct; 25(5):208-12. PubMed ID: 7474409
[TBL] [Abstract][Full Text] [Related]
4. Primary chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide in locally advanced thymomas: a single institution experience.
Berruti A; Borasio P; Gerbino A; Gorzegno G; Moschini T; Tampellini M; Ardissone F; Brizzi MP; Dolcetti A; Dogliotti L
Br J Cancer; 1999 Nov; 81(5):841-5. PubMed ID: 10555755
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy of invasive or metastatic thymoma: report of 11 cases.
Fornasiero A; Daniele O; Sperandio P; Morandi P; Fosser VP; Cartei G; Fiorentino MV
Cancer Treat Rep; 1984 Oct; 68(10):1205-10. PubMed ID: 6543151
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report.
Kim ES; Putnam JB; Komaki R; Walsh GL; Ro JY; Shin HJ; Truong M; Moon H; Swisher SG; Fossella FV; Khuri FR; Hong WK; Shin DM
Lung Cancer; 2004 Jun; 44(3):369-79. PubMed ID: 15140551
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy of invasive thymoma. A retrospective study of 22 cases.
Göldel N; Böning L; Fredrik A; Hölzel D; Hartenstein R; Wilmanns W
Cancer; 1989 Apr; 63(8):1493-500. PubMed ID: 2466548
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy and operation for invasive thymoma.
Rea F; Sartori F; Loy M; Calabrò F; Fornasiero A; Daniele O; Altavilla G
J Thorac Cardiovasc Surg; 1993 Sep; 106(3):543-9. PubMed ID: 8361199
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide (ADOC) in invasive thymomas: results in six patients.
Berruti A; Borasio P; Roncari A; Gorzegno G; Mossetti C; Dogliotti L
Ann Oncol; 1993 May; 4(5):429-31. PubMed ID: 8353078
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group.
Loehrer PJ; Kim K; Aisner SC; Livingston R; Einhorn LH; Johnson D; Blum R
J Clin Oncol; 1994 Jun; 12(6):1164-8. PubMed ID: 8201378
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial.
Loehrer PJ; Chen M; Kim K; Aisner SC; Einhorn LH; Livingston R; Johnson D
J Clin Oncol; 1997 Sep; 15(9):3093-9. PubMed ID: 9294472
[TBL] [Abstract][Full Text] [Related]
12. Combination chemotherapy with a five-drug regimen for invasive thymoma.
Bjerrum OW; Kiss K; Daugaard G
Acta Oncol; 1996; 35(1):71-3. PubMed ID: 8619943
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy for advanced thymoma. Preliminary results of an intergroup study.
Loehrer PJ; Perez CA; Roth LM; Greco A; Livingston RB; Einhorn LH
Ann Intern Med; 1990 Oct; 113(7):520-4. PubMed ID: 2203292
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy for advanced thymic carcinoma: clinical response to cisplatin, doxorubicin, vincristine, and cyclophosphamide (ADOC chemotherapy).
Koizumi T; Takabayashi Y; Yamagishi S; Tsushima K; Takamizawa A; Tsukadaira A; Yamamoto H; Yamazaki Y; Yamaguchi S; Fujimoto K; Kubo K; Hirose Y; Hirayama J; Saegusa H
Am J Clin Oncol; 2002 Jun; 25(3):266-8. PubMed ID: 12040285
[TBL] [Abstract][Full Text] [Related]
15. [A case of invasive thymoma made resectable by preoperative chemotherapy].
Tanaka K; Murota Y; Ando T; Asano K; Yamaguchi T; Wada G
Kyobu Geka; 1996 Sep; 49(10):868-71. PubMed ID: 8828336
[TBL] [Abstract][Full Text] [Related]
16. Thymoma. A retrospective study of 87 cases.
Park HS; Shin DM; Lee JS; Komaki R; Pollack A; Putnam JB; Cox JD; Hong WK
Cancer; 1994 May; 73(10):2491-8. PubMed ID: 8174044
[TBL] [Abstract][Full Text] [Related]
17. Remission of invasive thymoma due to chemotherapy. Two patients treated with cyclophosphamide, doxorubicin, and vincristine.
Loehrer PJ; Bonomi P; Goldman S; Reddy S; Faber LP; Jensik R; Dainauskas JR
Chest; 1985 Mar; 87(3):377-80. PubMed ID: 3971764
[TBL] [Abstract][Full Text] [Related]
18. Multidisciplinary treatment for advanced invasive thymoma with cisplatin, doxorubicin, and methylprednisolone.
Yokoi K; Matsuguma H; Nakahara R; Kondo T; Kamiyama Y; Mori K; Miyazawa N
J Thorac Oncol; 2007 Jan; 2(1):73-8. PubMed ID: 17410014
[TBL] [Abstract][Full Text] [Related]
19. [Invasive thymoma successfully treated with high-dose chemotherapy followed by peripheral blood stem cell transplantation(PBSCT)].
Iwasaki Y; Kubota Y; Yokomura I; Ueda M; Hashimoto S; Arimoto T; Inaba T; Shimazaki C; Nakagawa M; Toda S
Nihon Kokyuki Gakkai Zasshi; 1998 Mar; 36(3):288-93. PubMed ID: 9656679
[TBL] [Abstract][Full Text] [Related]
20. Objective response to epirubicin and lonidamine. A case of advanced thymoma previously treated with the ADOC scheme and unresponsive to paclitaxel plus cyclophosphamide.
Berruti A; Tampellini M; Gorzegno G; Dogliotti L
Chest; 1997 May; 111(5):1473-4. PubMed ID: 9149629
[No Abstract] [Full Text] [Related]
[Next] [New Search]
